Check out our comprehensive educational activities here

Recommended baseline cytogenetic molecular & immune profiling workup in newly diagnosed AML patients

Dr. Naval Daver discusses the recommended baseline cytogenetic molecular and immune profiling workup for a patient with newly diagnosed acute myeloid leukemia.

Published on May 31, 2017 in Diagnosis

Is molecular testing standard/routine for patients diagnosed with AML in the community setting?

Dr. Druker discusses whether routine molecular testing should be a part of the standard analysis of patients with AML in the community setting.

Published on May 31, 2017 in Diagnosis

What are the diagnostic requirements for acute myeloid leukemia?

Join Dr. Pratz as he explains the diagnostic requirements for acute myeloid leukemia, including the current World Health Organization criteria.

Published on May 31, 2017 in Diagnosis

What if an aspirate cannot be obtained on my patient?

Dr. Pratz will discuss alternate diagnostic options if an aspirate cannot be obtained on a patient with suspected AML.

Published on May 31, 2017 in Diagnosis

When do I suspect the diagnosis of acute myeloid leukemia?

Join Dr. Pratz as he discusses patient presentations that may be indicative of acute myeloid leukemia and what types of patients are at risk for this diagnosis.

Published on May 31, 2017 in Diagnosis